Erika Moore Taylor
Erika Moore Taylor is a biomedical engineer, scientist, assistant professor,[1] "Forbes 30 under 30 honoree,"[2][3][4] financial advisor, and the founder of a scholarship program that has been featured on CNBC.[5][6][7]
Biography
In 2013, Erika received a Bachelor of Science in biomedical engineering from Johns Hopkins University in Baltimore, Maryland. In 2018, she went on to obtain a Doctor of Philosophy in biomedical engineering at Duke University in Durham, North Carolina. She returned to Johns Hopkins University in 2018 and remained there as a Provost's Postdoctoral Fellow until 2020. Taylor currently works as an assistant professor[8][2] in the Department of Materials Science and Engineering[9] at the University of Florida in Gainesville. She "specializes in the use of biomaterials to alter the immune response of the body.”[10] She is aiming in particular to discover "applications for the autoimmune disorder lupus."[3]
Distinctions
Taylor has earned many distinctions. Here is a selection of them:
- 2017 Duke University Board of Trustees - Graduate Young Trustee[1]
- 2017 MIT Rising Stars in Biomedical Engineering and Science[1]
- 2018 Duke University Department of Biomedical Engineering - BME Award for Outstanding Doctoral Dissertation[1]
- 2021 Duke University Center of Exemplary Mentoring (UCEM) Research Summit - Keynote Speaker[11]
Awards and honors
Taylor's track record of obtaining numerous scholarships, fellowships, and endowments is quite remarkable. Here are just a sampling of her winnings:[1]
- 2009 Johns Hopkins University - Hodson-Gilliam Success Scholar
- 2012 U.N.C.F./Merck Science Initiative - U.N.C.F./Merck Undergraduate Research Fellowship
- 2013 Ford Foundation Fellowship[9]
- 2013 The Graduate School of Duke University - Dean's Graduate Fellowship
- 2013 The Graduate School of Duke University - James B. Duke Fellowship
- 2013 National Science Foundation - NSF Graduate Research Fellow
- Herbert Wertheim College of Engineering at UF - Rhines Rising Star Larry Hench Professorship[10]
Societies
- Tau Beta Pi National Engineering Honor Society[1]
Publications
Taylor has published many academic works including:
- CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells
Erica B. Peters, Nicolas Christoforou, Erika Moore, Jennifer L. West, and George A. Truskey - BioResearch Open Access, Vol. 4, No. 1 (2015)[12]
- Tumor Necrosis Factor Improves Vascularization in Osteogenic Grafts Engineered with Human Adipose-Derived Stem/Stromal Cells
Daphne L. Hutton, Renu Kondragunta, Erika Moore, Ben P. Hung, Xiaofeng Jia, Warren L. Grayson (2014)[13]
- Platelet-Derived Growth Factor and Spatiotemporal Cues Induce Development of Vascularized Bone Tissue by Adipose-Derived Stem Cells
Daphne L. Hutton, Erika M. Moore, Jeffrey M. Gimble, and Warren L. Grayson - Tissue Engineering Part A Vol. 19, No. 17-18 (2013)[14]
- Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions
Daphne L Hutton, Elizabeth A Logsdon, Erika M Moore, Feilim Mac Gabhann, Jeffrey M Gimble, Warren L Grayson - Tissue Eng Part A (2012)[15]
- Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathy
Kim J, Buchbinder N, Ammanuel S, Kim R, Moore E, O'Donnell N, Lee J, Kulikowicz E, Acharya S, Lee R, Johnston M (2013)[16]
References
- ^ a b c d e f "UF: Herbert Wertheim College of Engineering: Erika Moore". moore.mse.ufl.edu. Archived from the original on 2021-10-21. Retrieved 2021-03-24.
- ^ a b "Forbes 30 under 30: Healthcare". www.forbes.com. Retrieved 23 March 2021.
- ^ a b "Healthcare: Erika Moore, 29: Assistant Professor, University of Florida". www.forbes.com. Retrieved 23 March 2021.
- ^ "30 UNDER 30 - 2021 - Healthcare". Forbes.
- ^ "Dr. Erika Moore Taylor: CNBC Select Contributor". CNBC. 11 February 2021. Retrieved 23 March 2021.
- ^ "This Forbes 30 Under 30 honoree paid off $65,000 in debt before she finished grad school—and her husband's loans are next". www.cnbc.com. 23 January 2021. Retrieved 23 March 2021.
- ^ "Why I'm glad I brought up money on my first date with my now-husband". www.cnbc.com. 13 February 2021. Retrieved 24 March 2021.
- ^ "UF: J. Crayton Pruitt Family Department of Biomedical Engineering: Fall 2019 – Spring 2020". www.bme.ufl.edu. Retrieved 24 March 2021.
- ^ a b "Immune Cells for Tissue (Re)Generation". www.bme.ufl.edu. Retrieved 24 March 2021.
- ^ a b "Erika Moore shines as a Rhines Rising Star Larry Hench Professor". mse.ufl.edu. Retrieved 24 March 2021.
- ^ "Duke UCEM Holds Second Annual Research Summit". ucem.duke.edu. Retrieved 24 March 2021.
- ^ Peters, Erica B.; Christoforou, Nicolas; Moore, Erika; West, Jennifer L.; Truskey, George A. (2015). "CD45+ Cells Present Within Mesenchymal Stem Cell Populations Affect Network Formation of Blood-Derived Endothelial Outgrowth Cells". BioResearch Open Access. 4 (1): 75–88. doi:10.1089/biores.2014.0029. PMC 4497669. PMID 26309784.
- ^ Hutton, Daphne L.; Kondragunta, Renu; Moore, Erika M.; Hung, Ben P.; Jia, Xiaofeng; Grayson, Warren L. (2014). "Tumor Necrosis Factor Improves Vascularization in Osteogenic Grafts Engineered with Human Adipose-Derived Stem/Stromal Cells". PLOS ONE. 9 (9): e107199. Bibcode:2014PLoSO...9j7199H. doi:10.1371/journal.pone.0107199. PMC 4172477. PMID 25248109.
- ^ Hutton, Daphne L.; Moore, Erika M.; Gimble, Jeffrey M.; Grayson, Warren L. (2013). "Platelet-Derived Growth Factor and Spatiotemporal Cues Induce Development of Vascularized Bone Tissue by Adipose-Derived Stem Cells". Tissue Engineering Part A. 19 (17–18): 2076–2086. doi:10.1089/ten.TEA.2012.0752. PMC 3725877. PMID 23582144.
- ^ Hutton, D. L.; Logsdon, E. A.; Moore, E. M.; Mac Gabhann, F.; Gimble, J. M.; Grayson, W. L. (2012). "Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions". Tissue Engineering. Part A. 18 (15–16): 1729–40. doi:10.1089/ten.tea.2011.0599. PMC 3419853. PMID 22462659.
- ^ Kim, John; Buchbinder; Ammanuel; Kim; Moore; O'Donnell; Lee; Kulikowicz; Acharya; Lee; Johnston, Michael; Johnston, M. V. (2013). "Cost-effective therapeutic hypothermia treatment device for hypoxic ischemic encephalopathy". Medical Devices: Evidence and Research. 6: 1–10. doi:10.2147/MDER.S39254. PMC 3540914. PMID 23319871.